A Boots pharmacy in Durham is recruiting patients to the DURATION trial, testing whether community pharmacies can support clinical research following the NHS Pharmacy First rollout. The pilot could reshape how primary care trials adapt to changing patient pathways.
Music, dance, art, drama, and poetry therapies are effective in treating post-traumatic stress disorder (PTSD) in children and adolescents across the globe, according to new research from the University of Oxford.
Oxford\u2019s OpenSAFELY team wins the prestigious Queen Elizabeth Prize for revolutionising secure NHS data research, protecting patient privacy while unlocking life-saving health insights.
Early screening resulted in earlier detection for 40% of anomalies, including heart and limb issues. \r\n\r\nResearchers from the University of Oxford, together with colleagues from the NHS and other partners, have published the first population-level study linking first-trimester ultrasound practice with early detection rates for serious congenital anomalies.
In October 2025, researchers from the MRC Translational Immune Discovery Unit led activities on researching gut bacteria at Oxford Science + Ideas Festival.
A major new study led by the University of Oxford and global partners has exposed significant global blind spots in genomic surveillance of antimicrobial resistance (AMR), warning that large parts of the world lack the data needed to track and respond to emerging threats.
Researchers at the Nuffield Department of Population Health have produced a comprehensive new report outlining how a series of recent breakthroughs in treatment and early detection of chronic kidney disease (CKD) have markedly improved outcomes for more than 850 million people living with CKD worldwide. The \u201cSeminar\u201d, a clinically focused overview for the generalist, is published in The Lancet.
One of the UK\u2019s first Brain Health Clinics is marking two major milestones as it celebrates five years since it launched and more than 500 patients using its services.
Over the past year, Professor Blagden has been filming for Cancer Detectives: Finding the Cures, a new three-part documentary series from Channel 4 which follows three scientists on the front lines of cancer research across the UK.
Higher body mass index (BMI) is not linked to increased risk of death or other complications following shoulder replacement surgery, according to a new study by Epaminondas Markos Valsamis from NDORMS, University of Oxford.
Professor Rose McGready, Deputy Director of the Shoklo Malaria Research Unit (SMRU), part of the MORU Tropical Health Network within Oxford\u2019s Nuffield Department of Medicine, has been honoured with the 2026 Australian Capital Territory (ACT) Australian of the Year Award.
An exciting research culture event on 17 October 2025 highlighted an ongoing pilot mentorship programme in the department, developed and led by the WICN group.
Repetitive negative thoughts will be investigated using a range of cutting-edge brain science techniques as part of a new study led by the University of Oxford and funded by Wellcome.
The Life and Mind building, a \u00a3200 million world-class teaching and research facility, has been officially opened by Sir Paul Nurse, Principal Group Leader, The Francis Crick Institute, President Elect of the Royal Society, and 2001 Nobel Laureate in Physiology or Medicine.
New research from a randomised clinical trial provides the strongest long-term evidence yet comparing partial (PKR) and total (TKR) knee replacements for patients with osteoarthritis. Published in The Lancet Rheumatology, the study shows both PKR and TKR being equally effective and offering similar clinical outcomes.
Professor Tim Elliott and colleagues from Oxford Cancer and the Centre for Immuno-Oncology welcomed the Brazilian Minister of Health and senior officials for an official visit organised by the British Embassy in Brazil. The delegation met to exchange insights on cancer research, regulation, and public health, with discussions focusing on prevention, early diagnosis, and innovative treatments such as mRNA vaccines and immunotherapy.
A new international study co-led by Professor Arri Coomarasamy of the University of Birmingham and the Nuffield Department of Women\u2019s and Reproductive Health, University of Oxford, has shown that diagnosing postpartum haemorrhage (PPH) within the first 90 minutes after childbirth can be crucial in preventing maternal deaths.
Two Oxford University academics are to co-lead ambitious new research projects backed by\u202fEuropean Research Council (ERC) Synergy Grants, part of the EU\u2019s Horizon Europe research and innovation programme. Synergy Grants foster collaboration between outstanding researchers, enabling them to combine their expertise, knowledge and resources to push the boundaries of scientific discovery.
![\"Boots](\"https://www.medsci.ox.ac.uk/news/boots-pharmacy-duration-trial-recruitment-pilot/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n